Copyright Reports & Markets. All rights reserved.

Global and United States Spinal Fusion Biologics Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Spinal Fusion Biologics Product Introduction
    • 1.2 Global Spinal Fusion Biologics Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Spinal Fusion Biologics Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Spinal Fusion Biologics Sales in Volume for the Year 2017-2028
    • 1.3 United States Spinal Fusion Biologics Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Spinal Fusion Biologics Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Spinal Fusion Biologics Sales in Volume for the Year 2017-2028
    • 1.4 Spinal Fusion Biologics Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Spinal Fusion Biologics in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Spinal Fusion Biologics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Spinal Fusion Biologics Market Dynamics
      • 1.5.1 Spinal Fusion Biologics Industry Trends
      • 1.5.2 Spinal Fusion Biologics Market Drivers
      • 1.5.3 Spinal Fusion Biologics Market Challenges
      • 1.5.4 Spinal Fusion Biologics Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Spinal Fusion Biologics Market Segment by Type
      • 2.1.1 Bone Graft
      • 2.1.2 Bone Graft Substitute
      • 2.1.3 Platelet Rich Plasma (PRP)
      • 2.1.4 Other
    • 2.2 Global Spinal Fusion Biologics Market Size by Type
      • 2.2.1 Global Spinal Fusion Biologics Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Spinal Fusion Biologics Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Spinal Fusion Biologics Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Spinal Fusion Biologics Market Size by Type
      • 2.3.1 United States Spinal Fusion Biologics Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Spinal Fusion Biologics Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Spinal Fusion Biologics Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Spinal Fusion Biologics Market Segment by Application
      • 3.1.1 Hospital
      • 3.1.2 Clinic
      • 3.1.3 Other
    • 3.2 Global Spinal Fusion Biologics Market Size by Application
      • 3.2.1 Global Spinal Fusion Biologics Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Spinal Fusion Biologics Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Spinal Fusion Biologics Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Spinal Fusion Biologics Market Size by Application
      • 3.3.1 United States Spinal Fusion Biologics Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Spinal Fusion Biologics Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Spinal Fusion Biologics Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Spinal Fusion Biologics Competitor Landscape by Company

    • 4.1 Global Spinal Fusion Biologics Market Size by Company
      • 4.1.1 Top Global Spinal Fusion Biologics Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Spinal Fusion Biologics Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Spinal Fusion Biologics Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Spinal Fusion Biologics Price by Manufacturer (2017-2022)
    • 4.2 Global Spinal Fusion Biologics Concentration Ratio (CR)
      • 4.2.1 Spinal Fusion Biologics Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Spinal Fusion Biologics in 2021
      • 4.2.3 Global Spinal Fusion Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Spinal Fusion Biologics Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Spinal Fusion Biologics Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Spinal Fusion Biologics Product Type
      • 4.3.3 Date of International Manufacturers Enter into Spinal Fusion Biologics Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Spinal Fusion Biologics Market Size by Company
      • 4.5.1 Top Spinal Fusion Biologics Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Spinal Fusion Biologics Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Spinal Fusion Biologics Sales by Players (2020, 2021 & 2022)

    5 Global Spinal Fusion Biologics Market Size by Region

    • 5.1 Global Spinal Fusion Biologics Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Spinal Fusion Biologics Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Spinal Fusion Biologics Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Spinal Fusion Biologics Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Spinal Fusion Biologics Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Spinal Fusion Biologics Sales in Value by Region: 2017-2022
      • 5.3.2 Global Spinal Fusion Biologics Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Spinal Fusion Biologics Market Size YoY Growth 2017-2028
      • 6.1.2 North America Spinal Fusion Biologics Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Spinal Fusion Biologics Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Spinal Fusion Biologics Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Spinal Fusion Biologics Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Spinal Fusion Biologics Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Spinal Fusion Biologics Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Spinal Fusion Biologics Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Spinal Fusion Biologics Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Spinal Fusion Biologics Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Medtronic
      • 7.1.1 Medtronic Corporation Information
      • 7.1.2 Medtronic Description and Business Overview
      • 7.1.3 Medtronic Spinal Fusion Biologics Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Medtronic Spinal Fusion Biologics Products Offered
      • 7.1.5 Medtronic Recent Development
    • 7.2 J &J (DePuy Synthes)
      • 7.2.1 J &J (DePuy Synthes) Corporation Information
      • 7.2.2 J &J (DePuy Synthes) Description and Business Overview
      • 7.2.3 J &J (DePuy Synthes) Spinal Fusion Biologics Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 J &J (DePuy Synthes) Spinal Fusion Biologics Products Offered
      • 7.2.5 J &J (DePuy Synthes) Recent Development
    • 7.3 SeaSpine
      • 7.3.1 SeaSpine Corporation Information
      • 7.3.2 SeaSpine Description and Business Overview
      • 7.3.3 SeaSpine Spinal Fusion Biologics Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 SeaSpine Spinal Fusion Biologics Products Offered
      • 7.3.5 SeaSpine Recent Development
    • 7.4 Xtant Medical
      • 7.4.1 Xtant Medical Corporation Information
      • 7.4.2 Xtant Medical Description and Business Overview
      • 7.4.3 Xtant Medical Spinal Fusion Biologics Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Xtant Medical Spinal Fusion Biologics Products Offered
      • 7.4.5 Xtant Medical Recent Development
    • 7.5 Zimmer Biomet
      • 7.5.1 Zimmer Biomet Corporation Information
      • 7.5.2 Zimmer Biomet Description and Business Overview
      • 7.5.3 Zimmer Biomet Spinal Fusion Biologics Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Zimmer Biomet Spinal Fusion Biologics Products Offered
      • 7.5.5 Zimmer Biomet Recent Development
    • 7.6 Stryker
      • 7.6.1 Stryker Corporation Information
      • 7.6.2 Stryker Description and Business Overview
      • 7.6.3 Stryker Spinal Fusion Biologics Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Stryker Spinal Fusion Biologics Products Offered
      • 7.6.5 Stryker Recent Development
    • 7.7 Straumann
      • 7.7.1 Straumann Corporation Information
      • 7.7.2 Straumann Description and Business Overview
      • 7.7.3 Straumann Spinal Fusion Biologics Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 Straumann Spinal Fusion Biologics Products Offered
      • 7.7.5 Straumann Recent Development
    • 7.8 Wright Medical Group
      • 7.8.1 Wright Medical Group Corporation Information
      • 7.8.2 Wright Medical Group Description and Business Overview
      • 7.8.3 Wright Medical Group Spinal Fusion Biologics Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Wright Medical Group Spinal Fusion Biologics Products Offered
      • 7.8.5 Wright Medical Group Recent Development
    • 7.9 Hans Biomed
      • 7.9.1 Hans Biomed Corporation Information
      • 7.9.2 Hans Biomed Description and Business Overview
      • 7.9.3 Hans Biomed Spinal Fusion Biologics Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Hans Biomed Spinal Fusion Biologics Products Offered
      • 7.9.5 Hans Biomed Recent Development
    • 7.10 Arthrex
      • 7.10.1 Arthrex Corporation Information
      • 7.10.2 Arthrex Description and Business Overview
      • 7.10.3 Arthrex Spinal Fusion Biologics Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 Arthrex Spinal Fusion Biologics Products Offered
      • 7.10.5 Arthrex Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Spinal Fusion Biologics Industry Chain Analysis
    • 8.2 Spinal Fusion Biologics Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Spinal Fusion Biologics Distributors
    • 8.3 Spinal Fusion Biologics Production Mode & Process
    • 8.4 Spinal Fusion Biologics Sales and Marketing
      • 8.4.1 Spinal Fusion Biologics Sales Channels
      • 8.4.2 Spinal Fusion Biologics Distributors
    • 8.5 Spinal Fusion Biologics Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:

      Spinal biologics are an important component of lumbar interbody spine fusion. Biologics are substances that work to alter the local environment by affecting cellular activity, growth, and differentiation through inherent properties of osteogenesis, osteoinduction, and osteoconduction.
      Market Analysis and Insights: Global and United States Spinal Fusion Biologics Market
      This report focuses on global and United States Spinal Fusion Biologics market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Spinal Fusion Biologics market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Bone Graft accounting for % of the Spinal Fusion Biologics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Spinal Fusion Biologics market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global Spinal Fusion Biologics Scope and Market Size
      Spinal Fusion Biologics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Spinal Fusion Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Spinal Fusion Biologics market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Spinal Fusion Biologics market is segmented into
      Bone Graft
      Bone Graft Substitute
      Platelet Rich Plasma (PRP)
      Other
      Segment by Application, the Spinal Fusion Biologics market is segmented into
      Hospital
      Clinic
      Other
      Regional and Country-level Analysis
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Spinal Fusion Biologics Market Share Analysis
      Spinal Fusion Biologics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Spinal Fusion Biologics business, the date to enter into the Spinal Fusion Biologics market, Spinal Fusion Biologics product introduction, recent developments, etc.
      The major vendors covered:
      Medtronic
      J &J (DePuy Synthes)
      SeaSpine
      Xtant Medical
      Zimmer Biomet
      Stryker
      Straumann
      Wright Medical Group
      Hans Biomed
      Arthrex
      Buy now